ST6GALNAC4 and lung carcinoma: In the latter case, ST6GALNAC4 was found to “cap” short O-glycans, preventing their elongation by other glycosyltransferases, and in doing so, preserve galectin-3 binding to promote lung cancer metastasis (100).